Aziana has received firm commitments from its two largest shareholders for a $4 million capital raising it is undertaking as part of its reverse takeover of US-based biotech firm BrainChip.

Aziana has received firm commitments from its two largest shareholders for a $4 million capital raising it is undertaking as part of its reverse takeover of US-based biotech firm BrainChip.